Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesThe Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
Antimicrobial Agents and Chemotherapy, 07/01/09
Murakami T et al. - The compound shows an oral bioavailability of 25.6% in rats, and its oral administration blocks X4 HIV-1 replication in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse system. Thus, KRH-3955 is a new promising agent for HIV-1 infection and AIDS.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Innate immune responses to influenza A H5N1: friend or foe
Trends in Immunology, 10/30/09
Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways
Journal of Virology, 10/26/09
A Functional Polymorphism in MMP1 Could Influence Osteomyelitis Development
Journal of Bone and Mineral Research, 10/16/09
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Interventions for HIV-associated nephropathy
Cochrane Reviews, 10/20/09
Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09
Alternative Dosage of Zidovudine in Infants Exposed to Maternal Human Immunodeficiency Virus Infection
The Pediatric Infectious Disease Journal, 10/26/09
Article Search
Sponsor